Meta AnalysisID 4321
丹参酮IIA磺酸钠对脑梗死患者血脂的影响：随机临床试验的系统评价和Meta分析
CRD42021293909
Can sodium tanshinone IIA sulfonate further safely decrease blood lipid in patients with cerebral infarction on the basis of statin therapy?
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 4321
- Evidence Id
- 12879
- Core Evidence Id
- 12879
- Source Meta Analysis Id
- 4289
- Herb2 Meta Analysis Id
- HBMA004289
- Crd Id
- CRD42021293909
- Title
- Effect of sodium tanshinone IIA sulfonate on blood lipid in patients with cerebral infarction: a systematic review and meta-analysis of randomized clinical trials
- Review Question
- Can sodium tanshinone IIA sulfonate further safely decrease blood lipid in patients with cerebral infarction on the basis of statin therapy?
- Study Type Included
- randomised controlled trials
- Condition Being Studied
- cerebral infarction
- Participant
- Patients, of any age and gender, with cerebral infarction, diagnosed according to established diagnostic criteria.
- Animal
- Human Disease Modelled
- Intervention
- sodium tanshinone IIA sulfonate combined with conventional therapy
- Comparator Control
- conventional therapy
- Main Outcome
- Any lipid profile parameters, including total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglycerides (TG); frequencies of adverse events.
- Outcome Measure
- Additional Outcome
- Study Method
- Meta-analysis, Systematic review
- Keyword
- Cerebral Infarction; Humans; Lipids; Phenanthrenes; Randomized Controlled Trials as Topic; tanshinone II A sodium sulfonate
- Contact
- Li Chunyan [email protected]
- Organisational Affiliation
- Dongzhimen Hospital, Beijing University of Chinese Medicine http://www.dzmhospital.com/
- Funding Source
- National Natural Science Foundation of China (81973790); Subproject of key research project of Beijing University of traditional Chinese medicine (2020-jyb-zdgg-110-2)
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- 2021-11-28
- Registration Date
- 2021-12-28
- Anticipated Start Date
- 2021-12-20
- Anticipated Completion Date
- 2023-12-18
- Title Cn
- 丹参酮IIA磺酸钠对脑梗死患者血脂的影响：随机临床试验的系统评价和Meta分析
- Title En
- Effect of sodium tanshinone IIA sulfonate on blood lipid in patients with cerebral infarction: a systematic review and meta-analysis of randomized clinical trials
- Bilingual Status
- complete